Group Lifestyle Balance™ for Individuals With Stroke (GLB-CVA)

Study acronym: GLB-CVA
StatusActive, Not Recruiting
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Study completion pushed from Dec 30, 2026 to Dec 30, 2027 Show 4 more changesShow less
    • Eligibility criteria expanded, about 12 words
    • Secondary endpoints: details revised at 26 of 29 entries
    • Site details revised
    • Publications: details revised at 2 of 2 entries
  2. Study completion date: Dec 30, 2025 to Dec 30, 2026v14
  3. Study completion date: Dec 30, 2024 to Dec 30, 2025v13
  4. Study completion date: Dec 30, 2023 to Dec 30, 2024v12
  5. Study completion date: Dec 30, 2022 to Dec 30, 2023v11
Show 9 earlier versionsHide 9 earlier versions
  1. Primary completion date: Aug 30, 2021 to Dec 30, 2022
    • Study completion date: Dec 30, 2021 to Dec 30, 2022
    v10
  2. Primary completion date: Jun 30, 2021 to Aug 30, 2021
    • Study completion date: Sep 30, 2021 to Dec 30, 2021
    v9
  3. Publications: 1 to 2v8
  4. Secondary endpoints: 26 to 29v7
  5. Trial status: Recruiting to Active, Not Recruiting
    • Enrollment target: estimated 42 to confirmed 65
    • Site details revised
    v6
  6. Re-verified, no change to tracked fieldsv5
  7. Secondary endpoints: 25 to 26
    • Eligibility criteria expanded, about 3 words
    v4
  8. Enrollment target: 64 to 42
    • Start date changed from estimate of Jul 1, 2019 to Jul 8, 2019
    v3
  9. Secondary endpoints: 23 to 25
    • Study description expanded, about 149 words
    v2
  1. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this RCT is to examine the efficacy of the Group Lifestyle Balance (GLB) program adapted for people with stroke (CVA) on primary (weight) and secondary outcomes at 3, 6, 12 months from enrollment into the program.
Trial Details
NCT Number NCT03873467
Lead Sponsor Baylor Research Institute
Collaborators: National Institute on Disability, Independent Living, and Rehabilitation Research
Conditions
(from sponsor)		 Stroke
Related terms Motor Activity, Stroke, Weight Loss
Enrollment 65 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov